1. A pharmaceutical composition comprising a compound hydrogel prodrug thereof, for use in preventing, diagnosing and / or treating ocular narusheniya.2. A pharmaceutical composition comprising a compound hydrogel prodrug thereof, for use in intraocular inektsii.3. A pharmaceutical composition comprising a compound hydrogel prodrug thereof, for use in intraocular injection for the prevention, diagnosis and / or treatment of ocular narusheniya.4. A pharmaceutical composition according to Claim. 1 or 3, wherein the ocular disorder is, in particular, ocular eye violation of the front region or rear region of the eye violation glaza.5. A pharmaceutical composition according to claim 4, wherein the eye violation front of the eye is selected from the group consisting of aphakia. psevdofakiyu astigmatism blepharospasm cataracts conjunctival diseases conjunctivitis corneal diseases corneal ulcer dry eye syndromes eyelid diseases lacrimal apparatus diseases lacrimal duct obstruction myopia presbyopia pupillary disorders refractive disorders and strabizm.6. A pharmaceutical composition according to claim 1 or 2, wherein the eye violation back of the eye is selected from the group consisting of acute macular neyroretinopatiya. Behcets disease choroidal neovascularization diabetic uveitis histoplasmosis infections, such as fungal or caused by virus infection macular degeneration, such as acute macular degeneration, nonexudative age-related macular degeneration and exudative age-related macular degeneration edema, such as macular edema, macular cystic from
